Clonal origin of recurrent hepatocellular carcinomas

Area of Science:

• Hepatology
• Oncology
• Virology

Background:

• Hepatocellular carcinoma (HCC) recurrence post-treatment is a significant clinical challenge.
• Understanding the clonal origin of recurrent HCC is crucial for effective management.

Purpose of the Study:

• To investigate the clonal origin of recurrent hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) infection.
• To determine whether recurrent tumors arise from the primary tumor or represent independent neoplastic events.

Main Methods:

• Analysis of five pairs of hepatocellular carcinomas from individual hepatitis B surface antigen carriers.
• Determination of tumor clonality using integrated hepatitis B virus (HBV) DNA as a molecular marker.
• Southern blot analysis to detect viral DNA integration patterns.

Main Results:

• In two cases, the recurrent tumor shared the same integrated hepatitis B virus (HBV) DNA as the primary tumor, indicating clonal origin.
• In three cases, the recurrent tumors exhibited different HBV DNA integration patterns, suggesting de novo development.
• Tumor clonality analysis revealed heterogeneity in the origins of recurrent HCC.

Conclusions:

• Recurrent hepatocellular carcinoma (HCC) can originate from the initial tumor in some instances.
• In other cases, recurrent HCC represents distinct, de novo neoplasms.
• The findings highlight the complex clonal evolution of HCC in hepatitis B virus carriers.